É possível prever a mortalidade molecular em meduloblastomas pela análise dos receptores de membrana CD114?
Open Access
- 22 December 2023
- journal article
- Published by Associacao Medica do Parana in BioSCIENCE
- Vol. 81 (2) , 17
Abstract
Introduction: Medulloblastomas are the most common solid tumors of childhood and classified into 4 molecular subgroups: WNT, SHH, Group 3 and Group 4. Many studies seek to develop new chemotherapy drugs for medulloblastomas by identifying genes whose expression is new molecular targets for drugs, such as membrane receptors associated with cell replication. Objective: To evaluate the association of CD114 expression with mortality in patients with medulloblastoma. Methods: Review carried out collecting information published on virtual platforms in Portuguese and English. Initially, a search was carried out for descriptors related to the topic - neurosurgery, surgical oncology, molecular targeted therapy and medulloblastoma, with AND or OR search, considering the title and/or summary. Afterwards, only those that were most related to the topic were included, and the texts read in full. Finally, 23 articles were referred. Results: There is a difference in the expression of the CD114 membrane receptor between Group 3 and the other molecular groups, in addition to a difference between the SHH γ molecular subtype and the Group 3 α and Group 3 β molecular subtypes. There was no statistically significant difference between the other groups and subtypes. Regarding mortality, this review did not demonstrate statistical significance in the relationship between low and high expressions of this gene and mortality. Conclusion: There is no direct relationship between the expression of the CD114 membrane receptor and mortality in patients with medulloblastoma. However, additional studies are needed on the intracellular signaling pathways associated with this receptor and its gene, CSF3R.Keywords
This publication has 22 references indexed in Scilit:
- Medulloblastoma group 3 and 4 tumors comprise a clinically and biologically significant expression continuum reflecting human cerebellar developmentCell Reports, 2022
- The role of JAK/STAT signaling pathway and its inhibitors in diseasesInternational Immunopharmacology, 2020
- Medulloblastoma: Molecular Classification-Based Personal TherapeuticsNeurotherapeutics, 2017
- CD114: A New Member of the Neural Crest-Derived Cancer Stem Cell Marker FamilyJournal of Cellular Biochemistry, 2016
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summaryActa Neuropathologica, 2016
- Molecular subgroups of medulloblastoma: the current consensusActa Neuropathologica, 2011
- Progression from first symptom to diagnosis in childhood brain tumoursEuropean Journal of Pediatrics, 2011
- Granulocyte Colony-Stimulating Factor/Granulocyte Colony-Stimulating Factor Receptor Biological Axis Promotes Survival and Growth of Bladder Cancer CellsUrology, 2007
- Pathogenesis of medulloblastoma and current treatment outlookMedicinal Research Reviews, 2006
- Epidemiology of central nervous system tumors in childhood and adolescence based on the new WHO classificationChild's Nervous System, 2001